The aim of this study was to assess the outcome of treating glottic dysplasia and early squamous cell carcinoma (SCC) with potassium titanyl phosphate (KTP) photoangiolytic laser ablation.
Methods:
Patient demographics, comorbidities, and tumor characteristics were recorded. Perceptual, patient-reported, and objective voice outcomes were assessed. Use of treatment modalities in addition to the KTP laser, development of locoregional or metastatic SCC, and overall survival were recorded.
Results:
There were 23 patients with glottic dysplasia and 18 patients with glottic SCC. Mean age at treatment was 69 years. Most patients (95%) were male. Posttreatment fundamental frequency fell from 132 ± 35 to 116 ± 24 Hz (P = .03). Overall, 61% of patients achieved a normal voice. There was a learning-curve, and most treatment failures occurred in the first half of the series. Five-year KTP-only disease-control rates were 87.1% and 53.5% for dysplasia and malignancy, respectively. Five-year overall survival was 56%, with no laryngectomies or deaths due to SCC.
Conclusions:
Ablating dysplasia and early glottic cancer using a KTP laser is a viable treatment option. It has a learning curve and a failure rate but, in this series, no ultimate loss of oncologic control. Its introduction into clinical practice should be managed carefully in the context of multidisciplinary cancer care.
Clinical Audit Support Unit. National Head and Neck Cancer Audit 2014. Leeds, UK: Health and Social Care Information Centre;2015.
2.
JonesASFishBFentonJEHusbandDJ.The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?Head Neck. 2004;26(2):127-135.
3.
SjogrenEVvan RossumMALangeveldTPet al. Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg. 2008;134(9):965-972.
4.
WarnerLLeeKHomerJJ.Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes. Clin Otolaryngol. 2017;42(3):629-636.
5.
GaleNGneppDRPoljakMet al. Laryngeal squamous intraepithelial lesions: an updated review on etiology, classification, molecular changes, and treatment. Adv Anat Pathol. 2016;23(2):84-91.
6.
RoedelRMChristiansenHMuellerRMMatthiasC.Transoral laser microsurgery for carcinoma in situ of the glottic larynx. A retrospective follow-up study. ORL J Otorhinolaryngol Relat Spec. 2009;71(1):45-49.
7.
LeirensJVidtsGSchmelzerBdella FailleDKatzSVan CauwenbergeP.Premalignant lesions of the vocal cords. A retrospective study of 62 cases treated with CO2 laser. Acta Otolaryngol. 1997;117(6):903-908.
8.
DispenzaFDe StefanoAMarcheseDMartinesFDispenzaC.Management of laryngeal precancerous lesions. Auris Nasus Larynx. 2012;39(3):280-283.
9.
PlchJParINavratilovaIBlahovaMZavadilM.Long term follow-up study of laryngeal precancer. Auris Nasus Larynx. 1998;25(4):407-412.
MinniABarbaroMRispoliGDiaferiaFBernardeschiDFilipoR.Treatment with laser CO2 cordectomy and clinical implications in management of mild and moderate laryngeal precancerosis. Eur Arch Otorhinolaryngol. 2008;265(2):189-193.
12.
HartlDMde MonesEHansSJanotFBrasnuD.Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol. 2007;116(11):832-836.
13.
LeddaGPPuxedduR.Carbon dioxide laser microsurgery for early glottic carcinoma. Otolaryngol Head Neck Surg. 2006;134(6):911-915.
14.
MortuaireGFrancoisJWielEChevalierD.Local recurrence after CO2 laser cordectomy for early glottic carcinoma. Laryngoscope. 2006;116(1):101-105.
15.
PradhanSAPaiPSNeeliSID’CruzAK.Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg. 2003;129(6):623-625.
16.
PerettiGNicolaiPPiazzaCRedaellideZinisLOValentiniSAntonelliAR.Oncological results of endoscopic resections of Tis and T1 glottic carcinomas by carbon dioxide laser. Ann Otol Rhinol Laryngol. 2001;110(9):820-826.
17.
DammMSittelCStreppelMEckelHE.Transoral CO2 laser for surgical management of glottic carcinoma in situ. Laryngoscope. 2000;110(7):1215-1221.
18.
LeQTTakamiyaRShuHKet al. Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Arch Otolaryngol Head Neck Surg. 2000;126(11):1305-1312.
19.
MoreauPR.Treatment of laryngeal carcinomas by laser endoscopic microsurgery. Laryngoscope. 2000;110(6):1000-1006.
20.
De MonesEHansSHartlDMLaccourreyeOBrasnuD.[Carbon dioxide laser transoral microsurgery for glottic carcinoma in situ]. Ann Otolaryngol Chir Cervicofac. 2002;119(1):21-30.
21.
PlaatBEZwakenbergMAvan ZwolJGet al. Narrow-band imaging in transoral laser surgery for early glottic cancer in relation to clinical outcome. Head Neck. 2017;39(7):1343-1348.
22.
MahieuHFPatelPAnnyasAAvan der LaanT.Carbon dioxide laser vaporization in early glottic carcinoma. Arch Otolaryngol Head Neck Surg. 1994;120(4):383-387.
23.
ZeitelsSMBurnsJALopez-GuerraGAndersonRRHillmanRE.Photoangiolytic laser treatment of early glottic cancer: a new management strategy. Ann Otol Rhinol Laryngol Suppl. 2008;199:3-24.
24.
ZeitelsSMBurnsJA.Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer. Ann Otol Rhinol Laryngol. 2014;123(12):840-846.
25.
HiranoM.Clinical Examination of Voice. New York: Springer-Verlag; 1981.
26.
RosenCALeeASOsborneJZulloTMurryT.Development and validation of the Voice Handicap Index-10. Laryngoscope. 2004;114:1549-1556.
27.
LopezFAlvarez-MarcosCAlonso-GuervosMet al. From laryngeal epithelial precursor lesions to squamous carcinoma of the larynx: the role of cell cycle proteins and beta-catenin. Eur Arch Otorhinolaryngol. 2013;270(12):3153-3162.
28.
TheodosiouMGYiotakisJDikoglouCLazarisACAthanasiadis-SismanisAXenellisJ.Laryngeal dysplasia: a long-term follow-up study. J BUON. 2013;18(3):683-688.
29.
LuersJCSircarKDrebberUBeutnerD.The impact of laryngeal dysplasia on the development of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014;271(3):539-545.
30.
KrengliMPolicarpoMManfreddaIAluffiPGambaroGPanellaMet al. Voice quality after treatment for T1a glottic carcinoma—radiotherapy versus laser cordectomy. Acta Oncol. 2004;43(3):284-289.
31.
PeetersAJvan GoghCDGoorKMVerdonck-de LeeuwIMLangendijkJAMahieuHF.Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol. 2004;261(10):534-540.
32.
FinkDSSibleyHKundukMet al. Subjective and objective voice outcomes after transoral laser microsurgery for early glottic cancer. Laryngoscope. 2016;126(2):405-407.
33.
LiaoLJChouHWWangCTChungCSLaiMS.The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS ONE. 2013;8(4):e62116.
34.
HellquistHLundgrenJOlofssonJ.Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords—a follow-up study. Clin Otolaryngol Allied Sci. 1982;7(1):11-27.
35.
BlackwellKECalcaterraTCFuYS.Laryngeal dysplasia: epidemiology and treatment outcome. Ann Otol Rhinol Laryngol. 1995;104(8):596-602.
36.
SchweinfurthJMPowitzkyEOssoffRH.Regression of laryngeal dysplasia after serial microflap excision. Ann Otol Rhinol Laryngol. 2001;110(9):811-814.
37.
FrancoRAJr.ZeitelsSMFarinelliWAFaquinWAndersonRR.585-nm pulsed dye laser treatment of glottal dysplasia. Ann Otol Rhinol Laryngol. 2003;112(9Pt 1):751-758.
38.
SadriMMcMahonJParkerA.Management of laryngeal dysplasia: a review. Eur Arch Otorhinolaryngol. 2006;263(9):843-852.
39.
YeoJCConnorKLAdamsonRM.Laryngeal dysplasia: a prospective cohort study of 70 patients. Clin Otolaryngol. 2017;42(2):491-494.
40.
BahannanAASlavicekACernyLVokralJValentaZLohynskaRet al. Effectiveness of transoral laser microsurgery for precancerous lesions and early glottic cancer guided by analysis of voice quality. Head Neck. 2014;36(6):763-767.
41.
MuronoSEndoKKondoSWakisakaNYoshizakiT.Oncological and functional outcome after transoral 532-nm pulsed potassium-titanyl-phosphate laser surgery for T1a glottic carcinoma. Lasers Med Sci. 2013;28(2):615-619.
42.
RemacleMEckelHEAntonelliAet al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol. 2000;257(4):227-231.
43.
ZeitelsSMFrancoRAJr.DaileySHBurnsJAHillmanREAndersonRR.Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol. 2004;113(4):265-276.
44.
ZeitelsSMAkstLMBurnsJAHillmanREBroadhurstMSAndersonRR.Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006;115(9):679-685.
45.
MoHLLiJYangXZhangFXiongJWYangZLet al. Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci. 2017;32(2):461-467.
46.
KishimotoYSuzukiRKawaiYHiwatashiNKitamuraMTateyaIet al. Photocoagulation therapy for laryngeal dysplasia using angiolytic lasers. Eur Arch Otorhinolaryngol. 2016;273(5):1221-1225.
AlamMSPerweenRSiddiquiSA.Accelerated versus conventional radiation fractionation in early stage carcinoma larynx. Indian J Cancer. 2016;53(3):402-407.
50.
BlanchJLVilasecaIBernal-SprekelsenMet al. Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol. 2007;264:1045-1051.
51.
LundgrenJOlofssonJ.Malignant tumours in patients with non-invasive squamous cell lesions of the vocal cords. Clin Otolaryngol Allied Sci. 1987;12(1):39-43.
52.
BarbuAMBurnsJALopez-GuerraGLandau-ZemerTFriedmanADZeitelsSM.Salvage endoscopic angiolytic KTP laser treatment of early glottic cancer after failed radiotherapy. Ann Otol Rhinol Laryngol. 2013;122(4):235-239.
